Factors affecting the orr after neoadjuvant therapy of tp regimen combined with pd-1 inhibitors for esophageal cancer

HIGHLIGHTS

• who: Rulan Ma from the Jiaotong University have published the research: Factors affecting the ORR after neoadjuvant therapy of TP regimen combined with PD-1 inhibitors for esophageal cancer, in the Journal: Scientific Reports Scientific Reports
• what: This study evaluated the clinicopathological features and the laboratory hematological indexes that might affect the ORR of esophageal cancer patients after neoadjuvant therapy. Besides, in non-virus-related hepatocellular carcinoma, AST was enrolled for constructing a prognostic model to evaluate the OS of patients, and the model showed a good predictive au00ad bility35.
• how: The optimal . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.